Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Clera prepares and tests novel dopamine D2 receptor ligands

Dec. 5, 2006

Novel mGluR1 antagonist developed at Astellas

Dec. 5, 2006

Preclinical data support enhancement of TGF-beta signaling as a treatment for Alzheimer's disease

Dec. 5, 2006

Novel therapeutic agents for neurological disorders reported in recent patent literature

Dec. 4, 2006

Durect and Nycomed sign agreement for Posidur

Dec. 4, 2006

Spider toxins provide clues for understanding mechanisms of inflammatory pain

Dec. 4, 2006

Recent patents divulge novel analgesic agents

Dec. 1, 2006

Abuse-resistant PTI-202 safe and well tolerated in phase I study

Dec. 1, 2006

Genzyme acquires option for NsGene's neurotrophic factor NsG-33

Dec. 1, 2006

Pediatric exclusivity for Ambien and Ambien CR

Nov. 30, 2006

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...